Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-06

FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lamotrigine from Unichem Pharmaceuticals (USA), Inc., relating to the generic lamotrigine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)